Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 5, 2000, Pages 1575-1582

  Butler, Wayne M ^a   Merrick, Gregory S ^a,b   Dorsey, Anthony T ^a   Hagedorn, Brenda M ^c  

^a WHEELING HOSPITAL   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c WHEELING JESUIT UNIVERSITY   (United States)

Author keywords

Dose histograms; I 125; Pd 103; Prostate brachytherapy; Urethral dosimetry

Indexed keywords

IODINE 125; PALLADIUM; PALLADIUM 103; UNCLASSIFIED DRUG;

ARTICLE; BRACHYTHERAPY; CALCULATION; CATHETERIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HISTOGRAM; HUMAN; IMPLANT; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; TECHNIQUE; TREATMENT PLANNING; URETHRA; URINE CATHETER; VOLUMETRY;

BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IODINE RADIOISOTOPES; MALE; PALLADIUM; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOISOTOPES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; URETHRA;

EID: 0034565273     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01380-8     Document Type: Article

References (27)

1. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate cancer
2. Brachytherapy for clinically localized prostate cancer; Results at 7 and 8 year follow-up
3. Palladium-103 brachytherapy for prostate carcinoma
4. Tumor control and morbidity following transperineal I-125 implantation for stage T1/T2 prostatic carcinoma
5. 103Pd-based radiation for prostatic carcinoma
6. Potential role of various dosimetric quality indicators in prostate brachytherapy
7. The dependence of prostate postimplant dosimetric quality on CT volume determination
8. CT based dosimetry for transperineal I-125 prostate brachytherapy
9. A dose volume analysis of permanent transperineal prostatic brachytherapy
10. Evaluation of permanent I-125 prostate implants using radiography and magnetic imaging
11. A dose response study for I-125 prostate implants
12. Temporal resolution of urinary morbidity following prostate brachytherapy
13. Analysis of the dose-surface histogram and dose-wall histogram for the rectum and bladder
14. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis
15. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy
16. Acute urinary morbidity following I-125 interstitial implantation of the prostate gland
17. The impact of Gleason score accuracy as a criterion for prostate brachytherapy patient selection
18. Modified uniform seed loading for prostate brachytherapy; Rationale, design and evaluation
19. Comparison of seed loading approaches in prostate brachytherapy
20. Dosimetry of interstitial brachytherapy sources; Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43
21. Isotope choice and the effect of edema on prostate brachytherapy dosimetry
22. Refinements to the geometry factor used in AAPM Task Group Report No. 43 necessary for brachytherapy dosimetry calculations
23. 103Pd prostate seed implants
24. Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan
25. Effect of post-implant edema on the rectal dose in prostate brachytherapy
26. 3; Dosimetric analysis of implant quality